DXB
DIMERIX FPO [DXB]
Healthcare · ASX Small Cap
$0.4450 -6.3%
Updated 2026-03-02 · Scores refresh every scan
Appeared in 2 consecutive scans→ Score +3First seen: 2026-02-25
Score Breakdown
Technical41
Catalyst52
Sentiment50
Fundamental75
Momentum45
Risk Gate50
Active Signals
Bullish Signals
- RSI approaching oversold
- Near support level (potential bounce)
- Cash positive / operating cashflow positive
- 4C filed 2026-01-28
- Strong revenue growth (+249%)
- EPS estimates revised upward (+10pts)
- Strong revenue momentum (+249%)
- ASX200 bullish (+1.5% 5d)
- RBA cutting (+2pts)
- Trial readout: PHASE2 (est. 2020-06-16)
Risk Signals
- MACD momentum weakening
- Price below MAs (downtrend)
- Below 200-day MA (long-term downtrend)
- Deeply negative margins (-219%)
- Insufficient sentiment data (defaulting to neutral)
- Neutral/mixed sentiment
- Negative 12-1 momentum (-26%)
Recent Catalysts
LOW Dimerix Presents at Oppenheimer Life Sciences Conference
LOW Quarterly Appendix 4C and Activities Report
NONE Appendix 4D and Half Year Financial Report
NONE Dimerix to Present at Euroz Hartleys Healthcare Forum 2026
NONE Appointment of CFO/Company Secretary
Recent ASX Announcements
| 2026-02-26 | Dimerix Presents at Oppenheimer Life Sciences Conference |
| 2026-02-25 | Appendix 4D and Half Year Financial Report PRICE SENSITIVE |
| 2026-02-04 | Dimerix to Present at Euroz Hartleys Healthcare Forum 2026 |
| 2026-01-28 | Quarterly Appendix 4C and Activities Report PRICE SENSITIVE |
| 2026-01-20 | Appointment of CFO/Company Secretary |
Key Metrics
$285.2M
Market Cap
773K
Avg Volume
0.9x
Vol Ratio
$0.34 — $0.79
52-Week Range
0.1%
Short Interest
N/A
Cash Runway
-594.5%
ROE
-219.4%
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | fail | EPS Growth: 0% |
| A | Annual Earnings | fail | CAGR: 0% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | neutral | Float: 78% |
| L | Leader vs Laggard | laggard | RS: -3 |
| I | Institutional Sponsorship | weak | Inst: 1% |
| M | Market Direction | pass | Bullish |
Sector: Healthcare
Ranked #64 of 119 · Sector avg: 51
View all Healthcare signals →